IL-6, IL-23, and TGF-β and were seen in reduced levels at least in one post-infection period after L-Kyn and CH223191 treatments and this was accompanied by reduced levels of IL-17 (week 2) and IL-22 (both infection periods). This evidence concerns the gene IL17A and infection.